Context: The objective of this cross sectional study was to find out the relationship between the level of serum CK-MB and congestive cardiac failure.
Methods: In total 72 subjects of different socioeconomic class were included randomly and was divided in to four groups, 36 subjects were apparently healthy and 36 subjects were divided in to three groups according to NYHA staging of heart failure.
Results: The mean serum CK-MB was 0.897 ± 0.721 ng/ml among healthy subjects and 2.492 ± 2.535 ng/ml among the heart failure patients having significant difference (p<0.001) between two groups and the difference was more marked in NYHA class III group of heart failure patients.
Conclusions: These findings show that there was a definite rise of serum CK-MB level as heart failure advances. The evaluation suggests the use of CK-MB as a marker for staging of heart failure.